Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
RMSL
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
globenewswire.com
6 hours ago
prismmediawire.com
6 hours ago
globenewswire.com
6 hours ago
accessnewswire.com
7 hours ago
accessnewswire.com
8 hours ago
globenewswire.com
13 hours ago
Relative Strength
RMSL
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
REMSleep Holdings, Inc. focuses on the development and distribution of products to help people affected by sleep apnea worldwide. The company offers DeltaWave CPAP interface device to treat patients with sleep apnea. It serves home care dealers, private sleep labs, product end users, physicians, medical group, and hospitals, as well as medical associations. The company is headquartered in Tampa, Florida.
OTC
Unprofitable
Unprofitable
0.00Â ( 2.78%)
Relative Strenght
Volume Buzz
-100%
Earning Acce
No
Dist 52w H.
76%Earnings Growth
YoY
Current
Estimates
Q1.23
N/A
-0.00
vs -0.00
Q2.23
N/A
-0.00
vs -0.00
Q3.23
N/A
-0.00
vs -0.00
Q4.23
N/A
-0.00
vs -0.00
Q1.24
N/A
-0.00
vs -0.00
Q2.24
N/A
-0.00
vs -0.00
Q3.24
N/A
-0.00
vs -0.00
Q4.24
N/A
-0.00
vs -0.00
Q1.25
N/A
-0.00
vs -0.00
Q2.25
N/A
-0.00
vs -0.00
Sales Growth
YoY
Current
Estimates
Q1.23
NA
85.7K vs NA
Q2.23
-51%
58.7K vs 119.7K
Q3.23
-62%
51.9K vs 137.6K
Q4.23
-88%
7.5K vs 63.5K
Q1.24
-32%
57.9K vs 85.7K
Q2.24
-53%
27.6K vs 58.7K
Q3.24
-28%
37.3K vs 51.9K
Q4.24
-174%
-5550.00 vs 7.5K
Q1.25
-100%
NA vs 57.9K
Q2.25
-83%
4.8K vs 27.6K
Return on Equity
QoQ
Q1.23
-9%
-0.09
vs -0.16
Q2.23
-10%
-0.10
vs -0.09
Q3.23
-14%
-0.14
vs -0.10
Q4.23
-114%
-1.14
vs -0.14
Q1.24
-37%
-0.37
vs -1.14
Q2.24
-39%
-0.39
vs -0.37
Q3.24
-44%
-0.44
vs -0.39
Q4.24
-96%
-0.96
vs -0.44
Q1.25
-34%
-0.34
vs -0.96
Q2.25
-206%
-2.06
vs -0.34
Institutionnal Ownership
QoQ
Q1.23
1
1
vs 1
NA
Q2.23
1
1
vs 1
NA
Q3.23
1
1
vs 1
NA
Q4.23
1
1
vs 1
NA
Q1.24
1
1
vs 1
NA
Q2.24
1
1
vs 1
NA
Q3.24
NA
NA
vs NA
NA
Q4.24
1
1
vs NA
NA
Q1.25
1
1
vs 1
NA
Q2.25
2
2
vs 1
100%
Quote Panel
Key Metrics
Forecast
2025-Revenue
2025-EPS
2025-EBITDA
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Price Target
N/A(N/A)
Number of analyst
N/A
Last analyst upgrade/downgrade
No Data Available